Statin myotoxicity is associated with changes in the cardiopulmonary function

Atherosclerosis

Volumn 177, Issue 1, 2004, Pages 183-188

  Phillips, P S ^a   Phillips, C T ^b   Sullivan, M J ^a   Naviaux, R K ^c   Haas, R H ^c  

^a SCRIPPS MERCY HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UCSD MEDICAL CENTER   (United States)

Author keywords

Fatty acid oxidation; Myositis; Respiratory exchange ratio; Rhabdomyolysis; Statin; Toxicity

Indexed keywords

ATORVASTATIN; CERIVASTATIN; FENOFIBRATE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; NICOTINIC ACID; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; AIR CONDITIONING; ANAEROBIC THRESHOLD; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIET RESTRICTION; DYSPHAGIA; FEMALE; GAS ANALYSIS; HUMAN; LIPID OXIDATION; LUNG GAS EXCHANGE; MALE; MUSCLE CRAMP; MUSCLE WEAKNESS; MYALGIA; MYOSITIS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RHABDOMYOLYSIS; TOXICITY;

AGED; AGED, 80 AND OVER; ANTICHOLESTEREMIC AGENTS; BREATH TESTS; EXERCISE TEST; FATTY ACIDS; FEMALE; HEART; HUMANS; LUNG; MALE; MIDDLE AGED; MYOSITIS; OXIDATION-REDUCTION;

EID: 5444271174     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.06.014     Document Type: Article

References (22)

1. P.D. Thompson, P. Clarkson, and R.H. Karas Statin-associated myopathy JAMA 289 2003 1681 1690
2. R.C. Pasternak, S.C. Smith, and C.N. Bairey-Merz ACC/AHA/NHLBI Clinical advisory on the use and safety of statins J Am Coll Cardiol 40 2002 567 572
3. D. Gaist, L.A. Garcia Rodriguez, C. Huerta, J. Hallas, and S.H. Sindrup Lipid-lowering drugs and risk of myopathy: a population-based follow-up study Epidem 12 2001 565 569
4. K.C. Kordas, P.S. Phillips, and B.A. Golomb Clinical characteristics of 1053 patients with statin associated muscle complaints [abstract] Arteriosclero Thromb Vase Biol 24 2004 e51 e136
5. M. Castro Cabezas, de bruin TWA, and H.W. de Valk Impaired fatty acid metabolism in familial combined hyperlipidemia - a mechanism associating hepatic apolipoprotein B overproduction and insulin resistance J Clin Invest 92 1993 160 168
6. P.S. Phillips, R.H. Haas, S. Bannykh and the Scripps Mercy Clinical Research Center Statin Associated Myopathy with Normal Creatine Kinase Ann Int Med 137 2002 581 585
7. P.S. Phillips, R.H. Haas, and B. Barshop Utility of abnormal 3-methylglutaconic aciduria (3MGA) in diagnosing statin associated myopathy Atheroscler Throm Vase Biol Online J 22 2002 878
8. Jones NL. Clinical Exercise Testing. 4th ed. Appendix D. Philadelphia, PA: WB Saunders Company, 1997.
9. 2 uptake relationship during incremental exercise in man Exp Physiol 77 1992 51 64
10. M. De Lorgeril, P. Salen, and L. Bontemps Effects of lipid-lowering drugs on left ventricular function and exercise tolerance in dyslipidemic coronary patients J. Cardio Pharm 33 1999 473 478
11. A. Berg, M. Halle, M. Baumstark, J. Keul, and A. Northoff Spontaneously low LDL cholesterol and reaction to exercise-induced stress (letter) Lancet 347 1996 405
12. P.D. Thompson, G.J. Tsongalis, R.L. Seip, C. Bilbie, M. Miles, and R. Zoeller Apolipoprotein E genotype and changes in serum lipids and maximal oxygen uptake with exercise training Metabolism 53 2004 193 202
13. C.S. Reust, S.C. Curry, and J.R. Guidry Lovastatin use and muscle damage in healthy volunteers undergoing eccentric muscle exercise West J Med 154 1991 198 200
14. P.D. Thompson, J.M. Zmuda, and L.J. Domalik Lovastatin increases exercise-induced skeletal muscle injury Metabolism 46 1997 1206 1210
15. P.D. Thompson, A.M. Nugent, and P.N. Herber Increases in creatinine kinase after exercise in patients treated with HMG Co-A reductase inhibitors [letter] JAMA 264 1990 2992
16. H. Sinzinger, and J.O. O'Grady Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems Brit J Clin Pharm 57 2004 525 528
17. P.S. Phillips, B.J. Kimura, R. Kelley, and R.G. Thomas Feasibility of using the internet to perform medical research: observations from a statin-myopathy public information web site Circulation 107 2003 e7001 7039
18. J.E. Carroll, M.H. Brooke, and D.C. DeVivo Biochemical and physiologic consequences of carnitine palmityltransferase deficiency Muscle Nerve 1 1978 103 110
19. G. Paolisso, M. Barbagallo, and G. Petrella Effects of simvastatin and atorvastatin adminstration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent patients Atherosclerosis 150 2000 121 127
20. P. Durrington Hyperlipidaemia Lancet 362 2003 717 731
21. J.L. Goldstein, W.R. Hazzard, A.G. Schrott, E.L. Bierman, and A.G. Motulsky Hyperlipidemia in coronary heart disease: lipid levels in 500 survivors of myocardial infarction J Clin Invest 52 1973 1544 1568
22. E.Z. Nikkila, and A. Aro Family study of serum lipids and lipoproteins in coronary heart disease Lancet 1 1973 954 958